286 related articles for article (PubMed ID: 33268783)
1. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
[TBL] [Abstract][Full Text] [Related]
2. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
Mu M; Niu W; Zhang X; Hu S; Niu C
Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
[TBL] [Abstract][Full Text] [Related]
3. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033
[TBL] [Abstract][Full Text] [Related]
5. The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis.
Wang F; Zhang L; Luo Y; Zhang Q; Zhang Y; Shao Y; Yuan L
Mol Neurobiol; 2021 Jul; 58(7):3362-3373. PubMed ID: 33694060
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma.
Lu YF; Cai XL; Li ZZ; Lv J; Xiang YA; Chen JJ; Chen WJ; Sun WY; Liu XM; Chen JB
Cell Physiol Biochem; 2018; 45(5):1975-1985. PubMed ID: 29529599
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop.
Xu L; Wu Q; Yan H; Shu C; Fan W; Tong X; Li Q
Cancer Lett; 2022 Jan; 525():33-45. PubMed ID: 34728310
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling.
Yu H; Xu A; Wu B; Wang M; Chen Z
J Cell Physiol; 2021 Jan; 236(1):121-130. PubMed ID: 32803763
[TBL] [Abstract][Full Text] [Related]
11. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
[TBL] [Abstract][Full Text] [Related]
12. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
Chen L; Zhang J; Feng Y; Li R; Sun X; Du W; Piao X; Wang H; Yang D; Sun Y; Li X; Jiang T; Kang C; Li Y; Jiang C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1711-7. PubMed ID: 22750473
[TBL] [Abstract][Full Text] [Related]
13. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
[TBL] [Abstract][Full Text] [Related]
14. FAM87A as a Competing Endogenous RNA of miR-424-5p Suppresses Glioma Progression by Regulating PPM1H.
Xu H; Zhang H; Tan L; Yang Y; Wang H; Zhao Q; Lu J
Comput Math Methods Med; 2021; 2021():7952922. PubMed ID: 34712356
[TBL] [Abstract][Full Text] [Related]
15. lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway.
Zhou XY; Liu H; Ding ZB; Xi HP; Wang GW
Genomics; 2020 Jan; 112(1):1021-1029. PubMed ID: 31226483
[TBL] [Abstract][Full Text] [Related]
16. mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt/mTOR Signaling Pathway by Targeting VEGFA.
Liu Y; Wang Z; Tang Z; Fu Y; Wang L
Curr Cancer Drug Targets; 2024; 24(4):463-475. PubMed ID: 37592783
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protease Serine 8 Inhibits Glioma Cell Proliferation, Migration, and Invasion via Suppressing the Akt/mTOR Signaling Pathway.
Yang HY; Fang DZ; Ding LS; Hui XB; Liu D
Oncol Res; 2017 Jul; 25(6):923-930. PubMed ID: 27983922
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
Zhang L; Liang X; Li Y
Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
[TBL] [Abstract][Full Text] [Related]
19. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
Yang YF; Feng L; Shi Q; Wang LW; Hou LZ; Wang R; Fang JG
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8408-8417. PubMed ID: 32894548
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
